Cargando…
Suppression of tumor immune microenvironment via microRNA‐1 after epidermal growth factor receptor‐tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma
Immunotherapy is considered one of the most important therapeutic strategies for patients with lung adenocarcinoma after the development of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI) resistance. However, useful predictors of immunotherapy for these patients has not been ex...
Autores principales: | Kawana, Sachiko, Saito, Ryoko, Miki, Yasuhiro, Kimura, Yuichiro, Abe, Jiro, Sato, Ikuro, Endo, Mareyuki, Sugawara, Shunichi, Sasano, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877390/ https://www.ncbi.nlm.nih.gov/pubmed/33305905 http://dx.doi.org/10.1002/cam4.3639 |
Ejemplares similares
-
PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells
por: Inoue, Chihiro, et al.
Publicado: (2019) -
11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma
por: Saito, Ryoko, et al.
Publicado: (2020) -
EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer
por: Nanamiya, Ren, et al.
Publicado: (2021) -
Aromatase in human liver and its diseases
por: Hata, Shuko, et al.
Publicado: (2013) -
The correlation of p22(phox) and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma
por: Kobayashi, Masayuki, et al.
Publicado: (2019)